Dova Pharmaceuticals, Inc. (DOVA): Price and Financial Metrics


Dova Pharmaceuticals, Inc. (DOVA)

Today's Latest Price: $28.04 USD

0.04 (0.14%)

Updated Nov 11 7:58pm

Add DOVA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

See all "A" rated Strong Buy stocks

DOVA Stock Summary

  • With a price/sales ratio of 60.82, NA has a higher such ratio than 97.48% of stocks in our set.
  • As for revenue growth, note that DOVA's revenue has grown 189.88% over the past 12 months; that beats the revenue growth of 96.96% of US companies in our set.
  • In terms of volatility of its share price, DOVA is more volatile than 94.25% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to NA, a group of peers worth examining would be SNES, DERM, IGC, NEPT, and ECOR.
DOVA Daily Price Range
DOVA 52-Week Price Range

DOVA Stock Price Chart Technical Analysis Charts


DOVA Price/Volume Stats

Current price $28.04 52-week high $28.54
Prev. close $28.00 52-week low $5.62
Day low $28.00 Volume 1,488,000
Day high $28.19 Avg. volume 357,062
50-day MA $23.75 Dividend yield N/A
200-day MA $14.16 Market Cap 807.61M

Dova Pharmaceuticals, Inc. (DOVA) Company Bio


Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. The company was founded in 2016 and is based in Durham, North Carolina.


DOVA Latest News Stream


Event/Time News Detail
Loading, please wait...

DOVA Latest Social Stream


Loading social stream, please wait...

View Full DOVA Social Stream

DOVA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 38.88%
3-year 14.59%
5-year N/A
YTD N/A
2019 0.00%
2018 -73.68%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.4455 seconds.